拟人参皂苷RT5
b-D-Glucopyranoside, (3b,6a,12b,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl (9CI);Pseudoginsenoside RT5;(3beta,6alpha,12beta,24R)-3,12,25-trihydroxy-20,24-epoxydammaran-6-yl beta-D-glucopyranoside;b-D-Glucopyranoside;Pseudoginsenoside-RT5;pseudo-ginsenosides-RT4;(3beta,6alpha,12beta,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl beta-D-glucopyranoside;2-[[(5R,8R,9R,10R,13R,14R)-3,12-Dihydroxy-17-[(2S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4;HY-N0542;HY-N0542;b-D-Glucopyranoside,(3b,6a,12b,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl;b-D-Glucopyranoside,(3b,6a,12b,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl;(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S,5R)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol;Pseudoginsenoside Rt5;Pseudoginsenoside Rt5;98474-78-3;98474-78-3;CS-0009071;CS-0009071;AKOS030530367;AKOS030530367;MFCD10566641;MFCD10566641;Q-100912;Q-100912;MS-30984;MS-30984